NIP
AVNR

Nicholas Investment Partners’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Nicholas Investment Partners’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-138,965
Closed -$1.66M – 344
2014
Q3 		$1.66M Sell
138,965
-40,956
-23% -$280K 0.1% 264
2014
Q2 		$1.01M Buy
+179,921
New +$829K 0.06% 264

Other funds holding AVNR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Nicholas Investment Partners's AVNR Position: Q4 2014 in Review

Nicholas Investment Partners sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 138,965 shares — an estimated $1.66M sold.

Nicholas Investment Partners first reported a position in AVNR in Q2 2014 and held it in 2 quarters. The position peaked at $1.66M in Q3 2014. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

  • Nicholas Investment Partners reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
  • Nicholas Investment Partners sold 138,965 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $1.66M.
  • Nicholas Investment Partners first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2014 and held it in 2 quarters.
  • Nicholas Investment Partners's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.66M in Q3 2014.
  • 166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Nicholas Investment Partners's 13F filing for Q4 2014, filed 17 Feb 2015.